Horien Biochemical Technology Co., Ltd.

Research Horien Biochemical Technology Co., Ltd. (7814.TWO) on Bullrun: market cap TWD 1.26B, P/E 216.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.26B; P/E is 216.2.

Peer valuation comparison

Latest P/E is 216.15x versus a Healthcare sector median of 21.8x (891.8% above).

Latest P/E is 216.15x versus a Taiwan median of 18.67x (1057.9% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.26B216.2n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Horien Biochemical Technology Co., Ltd.

Horien Biochemical Technology Co., Ltd. operates as a supplier of cosmetic surgery raw materials and medical devices. The company develops collagen-based materials used in cosmetic applications, providing products, such as collagen dental matrix, gunne-plug, and extracellular membrane. Horien Biochemical Technology Co., Ltd. was founded in 2006 and is headquartered in Taichung, Taiwan.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is Horien Biochemical Technology Co., Ltd.'s market cap?

Horien Biochemical Technology Co., Ltd.'s market capitalization is TWD 1.26B.

What is Horien Biochemical Technology Co., Ltd.'s P/E ratio?

Horien Biochemical Technology Co., Ltd.'s price-to-earnings (P/E) ratio is 216.2.

What does Horien Biochemical Technology Co., Ltd. do?

Horien Biochemical Technology Co., Ltd. operates as a supplier of cosmetic surgery raw materials and medical devices. The company develops collagen-based materials used in cosmetic applications, providing products, such as collagen dental matrix, gunne-plug, and extracellular membrane. Horien Biochemical Technology Co., Ltd. was founded in 2006 and is headquartered in Taichung, Taiwan.